Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination 
Trump Attends Super Bowl Amid Cheers, Boos, and Political Divide 
Trump Signs Executive Order Targeting Big-Money College Athlete Payouts 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Thailand Inflation Remains Negative for 10th Straight Month in January 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
US Reviewing Visa Denial for Venezuelan Little League Team Barred from World Series 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out 
NBA Returns to China with Alibaba Partnership and Historic Macau Games 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
LA28 Confirms Olympic Athletes Exempt from Trump’s Travel Ban 
The late Lakers icon Kobe Bryant's investment for a 10 percent stake in sports drink BodyArmor for just $6 million in the company way back in 2014 has grown to $800 million.
That incredible gain surpassed by two and a half times more Bryant’s career NBA earnings of roughly $323 million in his 20 seasons playing for the Los Angeles Lakers.
When Coca-Cola acquired a minority stake in the sports drink company in 2018, Bryant's shares immediately soared to around $200 million.
Coca-Cola is reportedly close to acquiring a controlling stake in sports BodyArmor for $8 billion, which could be announced as early as Monday.
The Lakers icon keeps proving that he excelled outside the court.
After Bryant retired from the NBA in 2016, his "Dear Basketball" production brought him an Oscar for the best animated short film.
